Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Resverlogix Corp.. We currently have 0 research reports from 0 professional analysts.
Date | Source | Announcement |
---|---|---|
14Jun18 20:25 | GNW | Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone |
07Jun18 12:00 | GNW | Resverlogix Highlights Potential to Develop Apabetalone as a Therapeutic for HIV-1 Eradication Utilizing the "Shock and Kill" Approach |
25May18 06:45 | GNW | Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress |
19Mar18 11:00 | GNW | Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial |
08Jan18 14:09 | GNW | Resverlogix and Medison Pharma Ltd. Announce Strategic Licensing Agreement |
12Dec17 12:30 | GNW | Nature's Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1 |
04Dec17 12:00 | GNW | Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink |
Share: